Eduard, who has funding from the Federación Española de Fibrosis Quística for his project ‘Ribonucleotide reductase: a novel therapeutic target against bacterial pathogens in cystic fibrosis patients’, was awarded a share of the €200,000 raised this year by the the Catalan association of to help continue his research.
Cystic fibrosis, a degenerative disorder with a limited life expectancy for which there is no cure, is an inherited genetic disease affecting the lungs and digestive system. In Spain, cystic fibrosis affects one out of every 2,500 newborn babies.
